 | Up a level |
Masjedi, A and Ahmadi, A and Ghani, S and Malakotikhah, F and Nabi Afjadi, M and Irandoust, M and Karoon Kiani, F and Heydarzadeh Asl, S and Atyabi, F and Hassannia, H and Hojjat-Farsangi, M and Namdar, A. and Ghalamfarsa, G and Jadidi-Niaragh, F (2020) Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy. Nanomedicine: Nanotechnology, Biology, and Medicine, 29. ISSN 15499634
Yousefzadeh, Y and Hallaj, S and Baghi Moornani, M and Asghary, A and Azizi, G and Hojjat-Farsangi, M and Ghalamfarsa, G and Jadidi-Niaragh, F (2020) Tumor associated macrophages in the molecular pathogenesis of ovarian cancer. International Immunopharmacology, 84 (10647). ISSN 15675769
Hashemi, V and Farhadi, S and Ghasemi Chaleshtari, M and Seashore-Ludlow, B and Masjedi, A and Hojjat-Farsangi, M and Namdar, A and Ajjoolabady, A and Mohammadi, H and Ghalamfarsa, G and Jadidi-Niaragh, F (2020) Nanomedicine for improvement of dendritic cell-based cancer immunotherapy. International Immunopharmacology, 83. ISSN 15675769
Salimifard, S and Masjedi, A and Hojjat-Farsangi, M and Ghalamfarsa, G and Irandoust, M and Azizi, G and Mohammadi, H and Keramati, M.R and Jadidi-Niaragh, F (2020) Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer. Pathology Research and Practice, 216 (5). p. 152915. ISSN 03440338
Bastaki, S and Irandoust, M and Ahmadi, A and Hojjat-Farsangi, M and Ambrose, P and Hallaj, S and Edalati, M and Ghalamfarsa, G and Azizi, G and Yousefi, M and Chalajour, H and Jadidi-Niaragh, F (2020) PD-L1/PD-1 axis as a potent therapeutic target in breast cancer. Life Sciences, 247. p. 117437. ISSN 00243205
Masjedi, A and Ahmadi, A and Atyabi, F and Farhadi, S and Irandoust, M and Khazaei-Poul, Y and Ghasemi Chaleshtari, M and Edalati Fathabad, M and Baghaei, M and Haghnavaz, N and Baradaran, B and Hojjat-Farsangi, M and Ghalamfarsa, G and Sabz, G and Hasanzadeh, S and Jadidi-Niaragh, F (2020) Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression. International Journal of Biological Macromolecules, 149. pp. 487-500. ISSN 01418130
Masjedi, A and Hassannia, H and Atyabi, F and Rastegari, A and Hojjat-Farsangi, M and Namdar, A and Soleimanpour, H and Azizi, G and Nikkhoo, A and Ghalamfarsa, G and Mirshafiey, A and Jadidi-Niaragh, F (2019) Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathway. International Journal of Biological Macromolecules, 133. pp. 436-445. ISSN 01418130
Hosseini, S.M and Okoye, I and Chaleshtari, M.G and Hazhirkarzar, B and Mohamadnejad, J and Azizi, G and Hojjat-Farsangi, M and Mohammadi, H and Shotorbani, S.S and Jadidi-Niaragh, F (2019) E2 ubiquitin-conjugating enzymes in cancer: Implications for immunotherapeutic interventions. Clinica Chimica Acta, 498. pp. 126-134. ISSN Clinica Chimica Acta
Karpisheh, V and Nikkhoo, A and Hojjat-Farsangi, M and Namdar, A and Azizi, G and Ghalamfarsa, G and Sabz, G and Yousefi, M and Yousefi, B and Jadidi-Niaragh, F (2019) Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer. Prostaglandins and Other Lipid Mediators, 144. ISSN 10988823
Rostami, N and Nikkhoo, A and Ajjoolabady, A and Azizi, G and Hojjat-Farsangi, M and Ghalamfarsa, G and Yousefi, B and Yousefi, M and Jadidi-Niaragh, F (2019) S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy. Molecular Diagnosis and Therapy, 23 (4). pp. 467-487. ISSN 11771062
Kazemi, M.H and Mohseni, S.R and Hojjat-Farsangi, M and Anvari, E and Ghalamfarsa, G and Mohammadi, H and Jadidi-Niaragh, F (2018) Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer. Journal of Cellular Physiology, 233 (3). pp. 2032-2057.
Khamisipour, G and Jadidi-Niaragh, F and Jahromi, AS and Zandi, K and Hojjat-Farsangi, M (2016) Mechanisms of tumor cell resistance to the current targeted-therapy agents. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
